You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Myeloid

Showing 51 - 75 of 6,958
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)

Recruiting
  • Acute Myeloid Leukemia
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 13, 2022

Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Miami, Florida
    University of Miami
Dec 22, 2022

Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

Recruiting
  • Myelofibrosis
  • +2 more
  • Charlottesville, Virginia
    Danyelle Coley
Jan 18, 2023

Acute Myeloid Leukemia Trial (NK cells, Talazoparib 1 MG [Talzenna])

Not yet recruiting
  • Acute Myeloid Leukemia
  • NK cells
  • Talazoparib 1 MG [Talzenna]
  • (no location specified)
Jan 9, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Boston (BXCL701)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 26, 2023

Relapsed/Refractory Acute Myeloid Leukemia Trial in Hefei (gdT cell injection targeting B7-H3 chimeric antigen receptor)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • gdT cell injection targeting B7-H3 chimeric antigen receptor
  • Hefei, Anhui, China
    PersonGen Anke Cellular Therapeutice Co., Ltd.
Jan 31, 2023

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M.D. Anderson Cancer Center
Apr 17, 2023

Acute Myeloid Leukemia Trial in Valencia (AFM28)

Recruiting
  • Acute Myeloid Leukemia
  • Valencia, Spain
    Hospital Universitari i Politècnic La Fe
Apr 5, 2023

Leukemia Trial in California City, Chicago, Houston (GDX012, Chemotherapy Agents)

Not yet recruiting
  • Leukemia
  • California City, California
  • +2 more
May 24, 2023

Acute Myeloid Leukemia Trial in United States (Standard Leukemia Care, Palliative Care)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Standard Leukemia Care
  • Palliative Care
  • Boston, Massachusetts
  • +3 more
Jan 24, 2023

Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

Recruiting
  • Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • "3+7"
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Sep 29, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Acute Myeloid Leukemia Trial in Beijing, Tianjin (LCAR-AMDR Cells Product)

Recruiting
  • Acute Myeloid Leukemia
  • LCAR-AMDR Cells Product
  • Beijing, Beijing, China
  • +1 more
Jan 28, 2023

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Mold Infections in Children During Leukemia Treatment

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Acute Lymphoblastic Leukemia
    • Odense, Denmark
      Rasmus Møller Duus
    Mar 7, 2023

    Acute Myeloid Leukemia and Myelodysplastic Syndrome Trial in Tianjin (QLF32101)

    Not yet recruiting
    • Acute Myeloid Leukemia and Myelodysplastic Syndrome
    • Tianjin, Tianjin, China
      Institute of Hematology&Blood Diseases Hospital,Chinese Academy
    Jan 27, 2023

    Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Vienna, Austria
    • +3 more
    Jun 8, 2023

    Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Different induction chemotherapy regimens
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Sep 27, 2023

    Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Myeloid Leukemia Trial in United States

    Recruiting
    • Refractory Acute Myeloid Leukemia
    • +4 more
    • CD371-YSNVZ-IL18 CAR T cells
    • Basking Ridge, New Jersey
    • +6 more
    Aug 29, 2023

    MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • IFN-γ (interferon gamma-1b) injection
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jan 5, 2023

    Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Genetic Predisposition to Disease
    • Collection of blood sample of bone marrow (cohort 1)
    • Collection of blood sample of bone marrow (cohort 2 and 3)
    • (no location specified)
    Mar 6, 2023

    Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)

    Recruiting
    • Acute Myeloid Leukemia
    • Azacitidine Combined With Venetoclax and ATRA group
    • Suzhou, China
      the First Affiliated Hospital of Soochow University
    Dec 8, 2022

    Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

    Completed
    • Chronic Myeloid Leukemia
      • East Hanover, New Jersey
        Novartis
      Nov 20, 2023

      Relapsed/Refractory Acute Myeloid Leukemia Trial in Beijing

      Recruiting
      • Relapsed/Refractory Acute Myeloid Leukemia
      • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
      • Best-Available Therapy(BAT) Regimen
      • Beijing, Beijing, China
        Chinese PLA General Hospital
      Oct 10, 2023